Back

Cardiopulmonary exercise testing following conduction system versus biventricular pacing in heart failure: a substudy of the PhysioSync-HF randomized trial

30 August 2026 (16:15 - 16:45)
Organised by: Logo
Congress Presentation Part of: Heart failure: diagnosis and therapy Heart Failure with Reduced Ejection Fraction (HFrEF) ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Anderson Donelli Silveira

Hospital de Clínicas de Porto Alegre, Porto Alegre (Brazil)

4 More presentations in this session

Presentation thumbnail
Recovered vs remission heart failure among patients with LVEF improvement in non-Ischaemic HFrEF
Doctor T. Nabeta (Sagamihara, JP)
Abstract
Presentation thumbnail
Baseline characteristics of patients with HFrEF on dapagliflozin: final analysis of baseline data from the EVOLUTION-HF DEallEF study HFrEF cohort
Professor B. Assmus (Giessen, DE)
Abstract
Presentation thumbnail
Real-world barriers to long-term ARNI therapy in HFrEF: a one-year analysis of tolerability and dose achievement
Doctor M. Santos Silva (Aveiro, PT)
Abstract
Presentation thumbnail
GLP-1 receptor agonists added to guideline-directed medical therapy in heart failure with reduced ejection fraction: a propensity score-matched analysis
Doctor I. Chough (Stony Brook, US)
Abstract

Access the full session

Session thumbnail
Heart failure: diagnosis and therapy

The Event

Event poster

ESC Congress 2026

30 August 2026 16:15 CET
You may be interested in
thumbnail
Congress Session
Debates in cardiac resynchronisation therapy
30 March 2025
thumbnail
Congress Presentation
Cardiopulmonary exercise testing in Fontan patients: unmasking the secret of Super-Fontans
26 August 2022
thumbnail
Congress Presentation
From arterial hypertension to left ventricular hypertrophy and heart failure: role of CPET in heart failure with preserved ejection fraction patients evaluation
29 June 2021
thumbnail
Congress Presentation
Functional capacity improvement in patients with chronic heart failure treated with cardiac resynchronisation therapy is not associated with increased chronotropic reserve
13 April 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources